Ouchi T, Banba T, Matsumoto T, Suzuki S, Suzuki M
Department of Applied Chemistry, Faculty of Engineering, Kansai University, Osaka, Japan.
Drug Des Deliv. 1990 Oct;6(4):281-7.
With the object of providing an oligomeric prodrug of 5-fluorouracil (5FU) with reduced side-effects, affinity for tumor cells and high antitumor activity, 5FU was covalently attached to three chito-oligosaccharides (COS) through hexamethylene spacer groups via carbamoyl bonds. The ability of these conjugates to prolong the life of lymphocytic leukemia mice (following their intraperitoneal administration) and their tumor-inhibitory effects on Meth-A fibrosarcoma or MH-134 hepatoma mice (following their subcutaneous administration) were assessed. The conjugates caused a significant increase in the survival time of the p-388 leukemia mice, and higher growth-inhibitory effects against the solid tumor than either 5FU, COS, or blends of 5FU and COS. At the highest dose levels, the conjugates did not cause acute toxicity, and did not cause rapid decrease in body weight.
为了提供一种副作用降低、对肿瘤细胞有亲和力且具有高抗肿瘤活性的5-氟尿嘧啶(5FU)寡聚前药,通过六亚甲基间隔基团经氨基甲酰键将5FU共价连接到三种壳寡糖(COS)上。评估了这些缀合物延长淋巴细胞白血病小鼠寿命(腹腔注射后)的能力以及它们对Meth-A纤维肉瘤或MH-134肝癌小鼠的肿瘤抑制作用(皮下注射后)。这些缀合物使p-388白血病小鼠的存活时间显著增加,并且对实体瘤的生长抑制作用比5FU、COS或5FU与COS的混合物更高。在最高剂量水平下,这些缀合物不会引起急性毒性,也不会导致体重迅速下降。